Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Remimazolam on Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy

NCT05439057 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT05439057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Remimazolam on Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy
Lead sponsor
Inje University
Phase
Not applicable
Overall status
Completed
Start date
April 13, 2022
Completion date
October 31, 2024
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea and vomiting